Hawaii 2022 Regular Session

Hawaii House Bill HB1794 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	HOUSE OF REPRESENTATIVES H.B. NO. 1794 THIRTY-FIRST LEGISLATURE, 2022 H.D. 2 STATE OF HAWAII A BILL FOR AN ACT RELATING TO OPIOIDS. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
	1	+	HOUSE OF REPRESENTATIVES H.B. NO. 1794 THIRTY-FIRST LEGISLATURE, 2022 H.D. 1 STATE OF HAWAII A BILL FOR AN ACT RELATING TO OPIOIDS. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
2	2
3	3		HOUSE OF REPRESENTATIVES H.B. NO. 1794
4		-	THIRTY-FIRST LEGISLATURE, 2022 H.D. 2
	4	+	THIRTY-FIRST LEGISLATURE, 2022 H.D. 1
5	5		STATE OF HAWAII
6	6
7	7		HOUSE OF REPRESENTATIVES
8	8
9	9		H.B. NO.
10	10
11	11		1794
12	12
13	13		THIRTY-FIRST LEGISLATURE, 2022
14	14
15		-	H.D. 2
	15	+	H.D. 1
16	16
17	17		STATE OF HAWAII
18	18
19	19
20	20
21	21
22	22
23	23
24	24
25	25
26	26
27	27
28	28
29	29
30	30
31	31		A BILL FOR AN ACT
32	32
33	33
34	34
35	35
36	36
37	37		RELATING TO OPIOIDS.
38	38
39	39
40	40
41	41
42	42
43	43		BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
44	44
45	45
46	46
47		-	SECTION 1. Chapter 329E, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows: "§329E- Opioids; standardized metrics; value-based purchasing. (a) By ~~July~~ 1, 2024, the department of health shall develop and implement standardized quality metrics to track and address health care processes and outcomes applicable to: (1) The improvement of the quality of care; and (2) Targeting, through value-based purchasing, improvement in outcomes, for patients having opioid use disorders. (b) The quality metrics shall adhere to all applicable regulations and standards established by the federal Substance Abuse and Mental Health Services Administration. (c) By ~~January~~ 1, ~~2025~~, the department of health shall implement value-based purchasing based on the standardized quality metrics developed pursuant to subsection (a). The value-based purchasing shall be applicable to all state purchases of health and human services entered into after ~~January~~ 1, ~~2025~~. (d) The department of health shall require health service providers to collect and report to the department the following information: (1) Levels of prescribed opioids, including opioids dispensed for in-patient and emergency department use; (2) Inpatient and emergency department use for opioid use disorders; (3) Duration of medications for opioid use disorder pharmacotherapy; (4) Retention in treatment; and (5) Counseling rates. (e) The department of health shall submit an annual report to the legislature no later than twenty days prior to the convening of each regular session that includes: (1) A compilation of the data compiled pursuant to subsection (d); and (2) An update on the implementation of value-based purchasing. (f) As used in this section, "value-based purchasing" means a system that correlates payments to providers with measures of quality of care and outcomes delivered." SECTION 2. (a) There is established a working group within the department of health for administrative purposes. The working group shall determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care. In conducting its work, the working group shall consider: (1) What infrastructure needs to be developed; (2) What operations need to be redefined; (3) How to address provider workforce needs; (4) How to build new clinical practices; and (5) How to provide substance use disorder treatment providers with more support and information. (b) The working group shall consist of the following members: (1) The director of health, or the director's designee, who shall serve as chairperson of the working group; (2) A member of the senate, to be selected by the senate president; and (3) A member of the house of representatives, to be selected by the speaker of the house of representatives. (c) Representatives from the following organizations shall also be invited to serve on the working group: (1) Hawaii Substance Abuse Coalition; (2) Hawaii Medical Service Association; and (3) Any other agency or designee deemed appropriate by the chairperson of the working group. (d) The working group shall submit a report of its findings and recommendations, including any proposed legislation, to the legislature no later than twenty days prior to the convening of the regular session of 2023. (e) The working group shall cease to exist on June 30, 2023. SECTION 3. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date. SECTION 4. New statutory material is underscored. SECTION 5. This Act shall take effect on July 1, 2112.
	47	+	SECTION 1. Chapter 329E, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows: "§329E- Opioids; standardized metrics; value-based purchasing. (a) By January 1, 2024, the department of health shall develop and implement standardized quality metrics to track and address health care processes and outcomes applicable to: (1) The improvement of the quality of care; and (2) Targeting, through value-based purchasing, improvement in outcomes, for patients having opioid use disorders. (b) The quality metrics shall adhere to all applicable regulations and standards established by the federal Substance Abuse and Mental Health Services Administration. (c) By July 1, 2024, the department of health shall implement value-based purchasing based on the standardized quality metrics developed pursuant to subsection (a). The value-based purchasing shall be applicable to all state purchases of health and human services entered into after July 1, 2024. (d) The department of health shall require health service providers to collect and report to the department the following information: (1) Levels of prescribed opioids, including opioids dispensed for in-patient and emergency department use; (2) Inpatient and emergency department use for opioid use disorders; (3) Duration of medications for opioid use disorder pharmacotherapy; (4) Retention in treatment; and (5) Counseling rates. (e) The department of health shall submit an annual report to the legislature no later than twenty days prior to the convening of each regular session that includes: (1) A compilation of the data compiled pursuant to subsection (d); and (2) An update on the implementation of value-based purchasing. (f) As used in this section, "value-based purchasing" means a system that correlates payments to providers with measures of quality of care and outcomes delivered." SECTION 2. (a) There is established a working group within the department of health for administrative purposes. The working group shall determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care. In conducting its work, the working group shall consider: (1) What infrastructure needs to be developed; (2) What operations need to be redefined; (3) How to address provider workforce needs; (4) How to build new clinical practices; and (5) How to provide substance use disorder treatment providers with more support and information. (b) The working group shall consist of the following members: (1) The director of health, or the director's designee, who shall serve as chairperson of the working group; (2) A member of the senate, to be selected by the senate president; and (3) A member of the house of representatives, to be selected by the speaker of the house of representatives. (c) Representatives from the following organizations shall also be invited to serve on the working group: (1) Hawaii Substance Abuse Coalition; (2) Hawaii Medical Service Association; and (3) Any other agency or designee deemed appropriate by the chairperson of the working group. (d) The working group shall submit a report of its findings and recommendations, including any proposed legislation, to the legislature no later than twenty days prior to the convening of the regular session of 2023. (e) The working group shall cease to exist on June 30, 2023. SECTION 3. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date. SECTION 4. New statutory material is underscored. SECTION 5. This Act shall take effect on July 1, 2112.
48	48
49	49		SECTION 1. Chapter 329E, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
50	50
51		-	"§329E- Opioids; standardized metrics; value-based purchasing. (a) By ~~July~~ 1, 2024, the department of health shall develop and implement standardized quality metrics to track and address health care processes and outcomes applicable to:
	51	+	"§329E- Opioids; standardized metrics; value-based purchasing. (a) By January 1, 2024, the department of health shall develop and implement standardized quality metrics to track and address health care processes and outcomes applicable to:
52	52
53	53		(1) The improvement of the quality of care; and
54	54
55	55		(2) Targeting, through value-based purchasing, improvement in outcomes,
56	56
57	57		for patients having opioid use disorders.
58	58
59	59		(b) The quality metrics shall adhere to all applicable regulations and standards established by the federal Substance Abuse and Mental Health Services Administration.
60	60
61		-	(c) By ~~January~~ 1, ~~2025~~, the department of health shall implement value-based purchasing based on the standardized quality metrics developed pursuant to subsection (a). The value-based purchasing shall be applicable to all state purchases of health and human services entered into after ~~January~~ 1, ~~2025~~.
	61	+	(c) By July 1, 2024, the department of health shall implement value-based purchasing based on the standardized quality metrics developed pursuant to subsection (a). The value-based purchasing shall be applicable to all state purchases of health and human services entered into after July 1, 2024.
62	62
63	63		(d) The department of health shall require health service providers to collect and report to the department the following information:
64	64
65	65		(1) Levels of prescribed opioids, including opioids dispensed for in-patient and emergency department use;
66	66
67	67		(2) Inpatient and emergency department use for opioid use disorders;
68	68
69	69		(3) Duration of medications for opioid use disorder pharmacotherapy;
70	70
71	71		(4) Retention in treatment; and
72	72
73	73		(5) Counseling rates.
74	74
75	75		(e) The department of health shall submit an annual report to the legislature no later than twenty days prior to the convening of each regular session that includes:
76	76
77	77		(1) A compilation of the data compiled pursuant to subsection (d); and
78	78
79	79		(2) An update on the implementation of value-based purchasing.
80	80
81	81		(f) As used in this section, "value-based purchasing" means a system that correlates payments to providers with measures of quality of care and outcomes delivered."
82	82
83	83		SECTION 2. (a) There is established a working group within the department of health for administrative purposes. The working group shall determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care. In conducting its work, the working group shall consider:
84	84
85	85		(1) What infrastructure needs to be developed;
86	86
87	87		(2) What operations need to be redefined;
88	88
89	89		(3) How to address provider workforce needs;
90	90
91	91		(4) How to build new clinical practices; and
92	92
93	93		(5) How to provide substance use disorder treatment providers with more support and information.
94	94
95	95		(b) The working group shall consist of the following members:
96	96
97	97		(1) The director of health, or the director's designee, who shall serve as chairperson of the working group;
98	98
99	99		(2) A member of the senate, to be selected by the senate president; and
100	100
101	101		(3) A member of the house of representatives, to be selected by the speaker of the house of representatives.
102	102
103	103		(c) Representatives from the following organizations shall also be invited to serve on the working group:
104	104
105	105		(1) Hawaii Substance Abuse Coalition;
106	106
107	107		(2) Hawaii Medical Service Association; and
108	108
109	109		(3) Any other agency or designee deemed appropriate by the chairperson of the working group.
110	110
111	111		(d) The working group shall submit a report of its findings and recommendations, including any proposed legislation, to the legislature no later than twenty days prior to the convening of the regular session of 2023.
112	112
113	113		(e) The working group shall cease to exist on June 30, 2023.
114	114
115	115		SECTION 3. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.
116	116
117	117		SECTION 4. New statutory material is underscored.
118	118
119	119		SECTION 5. This Act shall take effect on July 1, 2112.
120	120
121	121
122	122
123		-	Report Title: DOH; Opioids; Standardized Metrics; Value-based Purchasing; Patient Outcomes; Working Group; Substance Use Disorder Description: Requires DOH to implement standardized quality metrics to track and address health care processes or outcomes applicable to improving the quality of care for patients having opioid use disorders and targeting through value-based purchasing improvements in outcomes for patients having opioid use disorders by 7/1/2024. Requires DOH to implement value-based purchasing based on the standardized quality metrics by 1/1/~~2025~~. Directs DOH to collect certain data regarding opioid use. Requires annual reports to the legislature. Establishes a working group to determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care. Effective 7/1/2112. (~~HD2~~) The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
	123	+	Report Title: DOH; Opioids; Standardized Metrics; Value-Based Purchasing; Patient Outcomes; Working Group; Substance Use Disorder Description: Requires DOH to implement standardized quality metrics to track and address health care processes or outcomes applicable to improving the quality of care for patients having opioid use disorders and targeting through value-based purchasing improvements in outcomes for patients having opioid use disorders by 1/1/2024. Requires DOH to implement value-based purchasing based on the standardized quality metrics by 7/1/2024. Directs DOH to collect certain data regarding opioid use. Requires annual reports to the legislature. Establishes a working group to determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care. Effective 7/1/2112. (HD1) The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
124	124
125	125
126	126
127	127		Report Title:
128	128
129	129		DOH; Opioids; Standardized Metrics; Value-Based Purchasing; Patient Outcomes; Working Group; Substance Use Disorder
130	130
131	131
132	132
133	133		Description:
134	134
135		-	Requires DOH to implement standardized quality metrics to track and address health care processes or outcomes applicable to improving the quality of care for patients having opioid use disorders and targeting through value-based purchasing improvements in outcomes for patients having opioid use disorders by 7/1/2024. Requires DOH to implement value-based purchasing based on the standardized quality metrics by 1/1/~~2025~~. Directs DOH to collect certain data regarding opioid use. Requires annual reports to the legislature. Establishes a working group to determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care. Effective 7/1/2112. (~~HD2~~)
	135	+	Requires DOH to implement standardized quality metrics to track and address health care processes or outcomes applicable to improving the quality of care for patients having opioid use disorders and targeting through value-based purchasing improvements in outcomes for patients having opioid use disorders by 1/1/2024. Requires DOH to implement value-based purchasing based on the standardized quality metrics by 7/1/2024. Directs DOH to collect certain data regarding opioid use. Requires annual reports to the legislature. Establishes a working group to determine major shifts in operations and clinical models that substance use disorder treatment providers need to make before adjusting to efforts to incentivize new demands for higher quality care. Effective 7/1/2112. (HD1)
136	136
137	137
138	138
139	139
140	140
141	141
142	142
143	143		The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.